Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09NAF
|
||||
Former ID |
DNCL002835
|
||||
Drug Name |
AV 133
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 3 | [548627] | ||
Company |
Avid Radiopharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | Synaptic vesicle amine transporter | Target Info | Enhancer | [532499] | |
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
5HT1 type receptor mediated signaling pathway | |||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathway | |||||
CCKR signaling map ST | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.